Leal Therapeutics is a biotechnology company dedicated to developing novel precision medicines for patients with high-need central nervous system disorders. Leal was launched in 2021 and is headquartered in Worcester, Mass.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/30/24 | $45,000,000 |
Alexandria Venture Investments Chugai Venture Fund Euclidean Capital Newpath Partners  OrbiMed Advisors PhiFund | undisclosed |
